Lyell Immunopharma Inc.
(LYEL)
undefined
undefined%
At close: undefined
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -0.52 | -45.09 | -1.65 | -5.24 | -8.59 |
| PS Ratio | 936.36 | 2.53 | 44.10 | 134.24 | 1584.75 |
| PB Ratio | 0.19 | 0.26 | 0.51 | 1.45 | 2.55 |
| P/FCF Ratio | -0.73 | -1.11 | -2.45 | -4.90 | 44.44 |
| P/OCF Ratio | -0.74 | -1.26 | -3.72 | -6.47 | 26.38 |
| OCF/S Ratio | -314.80 | -0.50 | -2.96 | -5.19 | 15.02 |
| Debt / Equity Ratio | 0.00 | 0.02 | 0.02 | 0.00 | 0.00 |
| Quick Ratio | 4.02 | 4.40 | 3.35 | 3.13 | 4.99 |
| Current Ratio | 4.02 | 4.40 | 3.35 | 3.13 | 4.99 |
| Asset Turnover | 0.00 | 0.09 | 0.01 | 0.01 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Equity (ROE) | -35.82% | -0.57% | -30.71% | -27.63% | -29.72% |
| Return on Assets (ROA) | -31.28% | -0.51% | -25.32% | -21.86% | -21.82% |
| Return on Capital (ROIC) | -34.52% | -20.33% | -19.87% | -24.67% | -19.13% |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Profit Margin | 25.00% | 20.14% | -9.12% | 0.91% | 25.00% |
| Net Profit Margin | -45121.54% | -1.40% | -670.19% | -639.93% | -4614.00% |